The 41-amino-acid C-terminal region of the hepatitis E virus ORF3 protein interacts with bikunin, a kunitz-type serine protease inhibitor

Journal of Virology

Volumn 79, Issue 18, 2005, Pages 12081-12087

  Tyagi, Shweta ^a,b   Surjit, Milan ^a   Lal, Sunil K ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; COMPLEMENTARY DNA; PHOSPHOPROTEIN; PROTEIN ORF3; SERINE PROTEINASE INHIBITOR; ULINASTATIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN COS1; CONTROLLED STUDY; DNA LIBRARY; FLUORESCENCE MICROSCOPY; HEPATITIS E VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; LIFE CYCLE; LIVER; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA VIRUS; VALIDATION PROCESS;

ALPHA-GLOBULINS; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA, VIRAL; HEPATITIS E VIRUS; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SERINE PROTEINASE INHIBITORS; TRYPSIN INHIBITOR, KUNITZ SOYBEAN; TWO-HYBRID SYSTEM TECHNIQUES; VIRAL PROTEINS;

HEPATITIS E VIRUS; MIRIDAE; RNA VIRUSES;

EID: 24644502576     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.18.12081-12087.2005     Document Type: Article

References (42)

1. Ansari, I. H., S. K. Nanda, H. Durgapal, S. Agrawal, S. K. Mohanty, D. Gupta, S. Jameel, and S. K. Panda. 2000. Cloning, sequencing, and expression of hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1). J. Med. Virol. 60:275-283.
2. Aye, T. T., T. Uchida, X.-Z. Ma, F. Iida, T. Shikata, H. Zhuang, and K. M. Win. 1992. Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res. 20:3512.
3. Aye, T. T., T. Uchida, X. Ma, F. Iida, T. Shikata, H. Zhuang, and K. M. Win. 1992. Sequence comparison of the capsid region of hepatitis E viruses isolated from Myanmar and China. Microbiol. Immunol. 36:615-621.
4. Aye, T. T., T. Uchida, X. Ma, F. Iida, T. Shikata, M. Ichikawa, T. Rikihisa, and K. Win. 1993. Sequence and gene structure of the hepatitis E virus isolated from Myanmar. Virus Genes 7:95-109.
5. Bai, C., and S. J. Elledge. 1996. Gene identification using the yeast two-hybrid system. Methods Enzymol. 273:331-347.
6. Berke, G. 1995. The CTL's kiss of death. Cell 81:9-12.
7. Bradley, D. W. 1990. Enterically-transmitted non-A, non-B hepatitis. Br. Med. Bull. 46:442-461.
8. Bratt, T., T. Cedervall, and B. Akerstrom. 1994. Processing and secretion of rat alpha 1-microglobulin-bikunin expressed in eukaryotic cell lines. FEBS Lett. 354:57-61.
9. Chen, L., S. J. T. Mao, and W. J. Larsen. 1992. Identification of a factor in fetal bovine serum that stabilizes the cumulus extracellular matrix. A role for a member of the inter-alpha-trypsin inhibitor family. J. Biol. Chem. 267:12380-12386.
10. Emerson, S. U., and R. H. Purcell. 2001. Recombinant vaccines for hepatitis E. Trends Mol. Med. 7:462-466.
11. Fries, E., and A. M. Blom. 2000. Bikunin-not just a plasma proteinase inhibitor. Int. J. Biochem. Cell Biol. 32:125-137.
12. He, J., A. W. Tam, P. O. Yarbough, G. R. Reyes, and M. Carl. 1993. Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells. J. Clin. Microbiol. 31:2167-2173.
13. Huang, R., N. Nakazono, K. Ishii, D. Li, O. Kawamata, R. Kawaguchi, and Y. Tsukada. 1995. Existing variations on the gene structure of hepatitis E virus strains from some regions of China. J. Med. Virol. 47:299-302.
14. Huang, R. T., D. R. Li, L. I. Wei, X. R. Huang, X. T. Yuan, and X. Tian. 1992. Isolation and identification of hepatitis E virus in Xinjiang, China. J. Gen. Virol. 73:1143-1148.
15. Jameel, S., M. Zafrullah, M. H. Ozdener, and S. K. Panda. 1996. Expression in animal cells and characterization of the hepatitis E virus structural proteins. J. Virol. 70:207-216.
16. Kaumeyer, J. F., J. O. Polazzi, and M. P. Kotick. 1986. The mRNA for a proteinase inhibitor related to the HI-30 domain of inter-alpha-trypsin inhibitor also encodes alpha-1-microglobulin (protein HC). Nucleic Acids Res. 14:7839-7850.
17. Khudyakov, Y. E., M. O. Favorov, D. L. Jue, T. K. Hine, and H. A. Fields. 1994. Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology 198:390-393.
18. Khudyakov, Y. E., N. S. Khudyakova, H. A. Fields, D. Jue, C. Starling, M. O. Favorov, K. Krawczynski, L. Polish, E. Mast, and H. Margolis. 1993. Epitope mapping in proteins of hepatitis E virus. Virology 194:89-96.
19. Kobayashi, H., M. Suzuki, Y. Hirashima, and T. Terao. 2003. Bikunin is a Kunitz-type protease inhibitor predominantly found in human amniotic fluid. Biol. Chem. 384:749-754.
20. Koonin, E. V., A. E. Gorbalenya, M. A, Purdy, M. N. Rozanov, G. R. Reyes, and D. W. Bradley. 1992. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-stranded RNA plant and animal viruses. Proc. Natl. Acad. Sci. USA 89:8259-8263.
21. Korkaya, H., S. Jameel, D. Gupta, S. Tyagi, R. Kumar, M. Zafrullah, M. Mazumdar, S. K. Lal, L. Xiaofang, D. Sehgal, S. R. Das, and D. Sahal. 2001. The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J. Biol. Chem. 276:42389-42400.
22. Lal, S. K., P. Tulasiram, and S. Jameel. 1997. Expression and characterization of the hepatitis E virus ORF3 protein in the methylotrophic yeast, Pichia pastoris. Gene 190:63-67.
23. Panda, S. K., I. H. Ansari, H. Durgapal, S. Agrawal, and S. Jameel. 2000. The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J. Virol. 74:2430-2437.
24. Panda, S. K., S. K. Nanda, M. Zafrullah, I.-H. Ansari, M. H. Ozdener, and S. Jameel. 1995. An Indian strain of hepatitis E virus (HEV): cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity. J. Clin. Microbiol. 33:2653-2659.
25. Purcell, R. H., and S. U. Emerson. 2000. Hepatitis E virus infection. Lancet 355:578.
26. Purcell, R. H., and J. R. Ticehurst. 1988. Enterically transmitted non-A, non-B hepatitis: epidemiology and clinical characteristics, p. 131-137. In A. J. Zukerman (ed.), Viral hepatitis and liver disease. Alan R. Liss, Inc., New York, N.Y.
27. Reyes, G. R., C. C. Huang, A. W. Tam, and M. A. Purdy. 1993. Molecular organization and replication of hepatitis E virus (HEV). Arch. Virol. 7:15-25.
28. Salier, J. P., P. Rouet, G. Raguenez, and M. Daveau. 1996. The inter-α-inhibitor family: from structure to regulation. Biochem. J. 315:1-9.
29. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
30. Shresta, S., C. T. Pham, D. A. Thomas, T. A. Graubert, and T. J. Ley. 1998. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10:581-587.
31. Sjoberg, E. M., and E. Fries. 1990. One of the major sulphated proteins secreted by rat hepatocytes contains low-sulphated chondroitin sulphate. Biochem. J. 272:113-118.
32. Tam, A. W., M. M. Smith, M. E. Guerra, C. C. Huang, D. W. Bradley, K. E. Fry, and G. R. Reyes. 1991. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185:120-131.
33. Tam, A. W., R. White, E. Reed, M. Short, Y. Zhang, T. R. Fuerst, and R. E. Lanford. 1996. In vitro propagation and production of hepatitis E virus from in vivo-infected primary macaque hepatocytes. Virology 215:1-9.
34. Tam, A. W., R. White, P. O. Yarbough, B. J. Murphy, C. P. McAtee, R. E. Lanford, and T. R. Fuerst. 1997. In vitro infection and replication of hepatitis E virus in primary cynomolgus macaque hepatocytes. Virology 238:94-102.
35. Tsarev, S. A., S. U. Emerson, G. R. Rees, T. S. Tsareva, L. J. Letgers, I. A. Malik, M. Iqbal, and R. H. Purcell. 1992. Characterization of a prototype strain of hepatitis E virus. Proc. Natl. Acad. Sci. USA 89:559-563.
36. Tyagi, S., S. Jameel, and S. K. Lal. 2001. A yeast two-hybrid study on self-association of the ORF2 protein of hepatitis E virus. Biochem. Biophys. Res. Commun. 284:614-621.
37. Tyagi, S., S. Jameel, and S. K. Lal. 2001. Self-association and mapping of the interaction domain of hepatitis E virus ORF3 protein. J. Virol. 75:2493-2498.
38. Tyagi, S., H. Korkaya, M. Zafrullah, S. Jameel, and S. K. Lal. 2002. The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2. J. Biol. Chem. 277:22759-22767.
39. 1-microglobulin/bikunin precursor (AMBP) and expedites their export from the hepatocyte. J. Biol. Chem. 279:29308-29319.
40. Wilharm, E., M. A. A. Parry, R. Friebel, H. Tschesche, G. Matschiner, C. P. Sommerhoff, and D. E. Jenne. 1999. Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma. J. Biol. Chem. 274:27331-27337.
41. Yin, S., R. H. Purcell, and S. U. Emerson. 1994. A new Chinese isolate of hepatitis E virus: comparison with strains recovered from different geographical regions. Virus Genes 9:23-32.
42. Zafrullah, M., M. H. Ozdener, S. K. Panda, and S. Jameel. 1997. The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J. Virol. 71:9045-9053.